Shrestha R, Llaurado Fernandez M, Dawson A, Hoenisch J, et al. Multiomics characterization of low-grade serous ovarian carcinoma identifies potential biomarkers of MEK inhibitor sensitivity and therapeutic vulnerability. Cancer Res 2021 Jan 13. pii: 0008-5472.CAN-20-2222.
PMID: 33441310